Correlation of serum homocysteine and previous history of gestational diabetes mellitus

Journal of Diabetes & Metabolic Disorders volume 12, Article number: 34 (2013) Cite this article

Abstract

Background

Gestational diabetes mellitus (GDM) is a common pregnancy condition. In this study, the risk of having a history of previous GDM (pGDM) on serum homocysteine level was assessed

Methods

Biomedical parameters, serum homocysteine, Insulin, homeostatic model assessment (HOMA) in women with (n = 52) and without pGDM (n = 51) were assessed. According to their current status of Oral Glucose Tolerance Test (GTT), the participants in each group were divided into two subgroups of normal or impaired GTT.

Results

Mean serum homocysteine in normal women was 8.56 ± 3.19 vs 11.44 ± 7.34 μmol/L (p < 0.01) in women with pGDM. Two groups had significant differences in respect to serum insulin levels (8.35 ± 5.12 vs 12.48 ± 5.44, p < 0.002), and HOMA-IR (1.90 ± 1.30 vs 2.91 ± 1.30, p < 0.002). In women without pGDM, serum homocysteine in normal and impaired GTT were 7.60 ± 1.69 and 10.52 ± 3.65 μmol/L (p = 0.03), respectively, while in women with pGDM, the figures were 8.38 ± 2.52 and 14.00 ± 10.17 (p < 0.01), respectively. In multi regression analysis an association between history of GDM and homocysteine levels was presented (OR: 7.71, 95% CI: 1.67-35.42, p < 0.001).

Conclusion

A trend of elevation of homocysteine is presented in women with pGDM, that is more prominent in women with impaired GTT, and shows a significant correlation with history of GDM. Further studies with larger sample size are suggested.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

US$ 39.95

Tax calculation will be finalised during checkout.

Abbreviations

GDM:

Gestational diabetes mellitus

FBS:

Fasting blood sugar

GTT:

Glucose tolerance test

N-GTT:

Normal glucose tolerance test

I-GTT:

Impaired glucose tolerance test

TG:

Triglyceride

HDL:

High density lipoprotein

LDL:

Low density lipoprotein

HOMA:

Homoeostasis model assessment.

References

  1. 1.

    Ural SH, Repke JT: Gestational diabetes mellitus. Gilmartin AB. Rev Obstet Gynecol 2008,1(3):129–134. Summer

    PubMed  PubMed Central  Google Scholar 

  2. 2.

    Hossein-Nezhad A, Maghbooli Z, Vassigh AR, et al.: Prevalence of gestational diabetes mellitus and pregnancy outcomes in Iranian women. Taiwan J Obstet Gynecol 2007,46(3):236–241. 10.1016/S1028-4559(08)60026-1

    Article  Google Scholar 

  3. 3.

    Stuebe AM, Mantzoros C, Kleinman K, et al.: Gestational glucose tolerance and maternal metabolic profile at 3 years postpartum. Obstet Gynecol 2011,118(5):1065–1073. 10.1097/AOG.0b013e3182325f5a

    CAS  Article  Google Scholar 

  4. 4.

    Vrachnis N, Augoulea A, Iliodromiti Z, Lambrinoudaki I, Sifakis S, Creatsas G: Previous gestational diabetes mellitus and markers of cardiovascular risk. Int J Endocrinol. 2012, 2012: 458610.

    PubMed  PubMed Central  Google Scholar 

  5. 5.

    Kelly PJ, Rosand J, Plomaritoglou A, Chang Y, Kistler JP, Furie K: Mild-moderate hyperhomocysteinaemia and risk of stroke, result of a metaanalysis. Stroke 2000, 32: 366.

    Google Scholar 

  6. 6.

    Sheu WH, Lee WK, Chen YT: Plasma homocysteine concentrations and insulin sensitivity in hypertensive subjects. Am J Hypertens 2000, 13: 14–20. 10.1016/S0895-7061(99)00138-7

    CAS  Article  Google Scholar 

  7. 7.

    Meigs JB, Jacques PF, Selhub J, et al.: Fasting plasma homocysteine levels in the insulin resistance syndrome: Framingham Offspring Study. Diab Care 2001, 24: 1403–1410. 10.2337/diacare.24.8.1403

    CAS  Article  Google Scholar 

  8. 8.

    Bar-On H, Kidron M, Friedlander Y, et al.: Plasma total homocysteine levels in subjects with hyperinsulinemia. J Intern Med 2000, 247: 287–297. 10.1046/j.1365-2796.2000.00592.x

    CAS  Article  Google Scholar 

  9. 9.

    Rosolová H, Simon J, Mayer O Jr, Racek J, Dierzé T, Jacobsen DW: Unexpected inverse relationship between insulin resistance and serum homocysteine in healthy subjects. Physiol Res 2002,51(1):93–98.

    PubMed  Google Scholar 

  10. 10.

    American Diabetes Association: Gestational Diabetes Mellitus. Diab Care 2004, 27: S88-S90.

    Article  Google Scholar 

  11. 11.

    Alfthan G, Laurinen MS, Valsta LM, Pastinen T, Aro A: Folate intake, plasma folate and homocysteine status in a random Finnish population. Eur J Clin Nutr 2003, 57: 81–88. 10.1038/sj.ejcn.1601507

    CAS  Article  Google Scholar 

  12. 12.

    DeFronzo RA, Abdul-Ghani MAJ: Preservation of β-cell function: the key to diabetes prevention. Clin Endocrinol Metab 2011,96(8):2354–2366. 10.1210/jc.2011-0246

    CAS  Article  Google Scholar 

  13. 13.

    Wajchenberg BL: beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev 2007,28(2):187–218.

    CAS  Article  Google Scholar 

  14. 14.

    Bonora E, Saggiani F, Targher G, et al.: Homeostasis Model Assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity. Diab Care 2000, 23: 23–25. 10.2337/diacare.23.1.23

    Article  Google Scholar 

  15. 15.

    Molęda P, Homa K, Safranow K, Celewicz Z, Fronczyk A, Majkowska L: Women with normal glucose tolerance and a history of gestational diabetes show significant impairment of β-cell function at normal insulin sensitivity. Diabetes Metab 2013,39(2):155–162. 10.1016/j.diabet.2012.11.003

    Article  Google Scholar 

  16. 16.

    Guven MA, Kilinc M, Batukan C, Ekerbicer HC, Aksu T: Elevated second trimester serum homocysteine levels in women with gestational diabetes mellitus. Arch Gynecol Obstet 2006, 274: 333–337. 10.1007/s00404-006-0191-6

    CAS  Article  Google Scholar 

  17. 17.

    Tarim E, Yigit F, Kilicdag E, et al.: Early onset of subclinical atherosclerosis in women with gestational diabetes mellitus. Ultrasound Obstet Gynecol 2006,27(2):177–182. 10.1002/uog.2687

    CAS  Article  Google Scholar 

  18. 18.

    Guldener CV: Why is homocysteine elevated in renal failure and what can be expected from homocysteine-lowering? Nephrol Dial Transplant 2006, 21: 1161–1166. 10.1093/ndt/gfl044

    Article  Google Scholar 

  19. 19.

    Wierzbicki AS: Homocysteine and cardiovascular disease: a review of the evidence. Diab Vasc Dis Res 2007, 4: 143.

    Article  Google Scholar 

  20. 20.

    Moat SJ, McDowell IF: Homocysteine and endothelial function in human studies. Semin Vasc Med 2005,5(2):172–182. 10.1055/s-2005-872402

    Article  Google Scholar 

Download references

Author information

Affiliations

  1. Elderly Health Research Center, Endocrinology and Metabolism population Sciences Institute, Tehran University of Medical Sciences, North Karegar Avenue, Dr Shariati Hospital, 5th floor, Tehran, 1411413137, Iran

    Sudabeh Alatab, Hossein Fakhrzadeh, Farshad Sharifi, Mojde Mirarefin, Zohreh Badamchizadeh & Maryam Ghaderpanahi

  2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hossein Fakhrzadeh, Arash Hossein-nezhad & Bagher Larijani

Authors
  1. Sudabeh Alatab
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hossein Fakhrzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Farshad Sharifi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mojde Mirarefin
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zohreh Badamchizadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maryam Ghaderpanahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Arash Hossein-nezhad
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hossein Fakhrzadeh.

Additional information

Competing interest

The authors report no conflict of interest.

Authors’ contributions

SA: Drafted the manuscript. HF: designed the study, intellectually revised the manuscript. FSh: designed the study, performed the analysis. MM: participated in study design. ZB: collected the data. MGH: participated in study design. AH: participated in study design. BL: approved the final version. All authors read and approved the final manuscript.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Alatab, S., Fakhrzadeh, H., Sharifi, F. et al. Correlation of serum homocysteine and previous history of gestational diabetes mellitus. J Diabetes Metab Disord 12, 34 (2013). https://doi.org/10.1186/2251-6581-12-34

Download citation

Keywords

  • Gestational diabetes mellitus
  • Homocysteine
  • Diabetes mellitus